Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 2
1992 3
1993 2
1994 1
1995 11
1996 6
1997 6
1998 11
1999 11
2000 15
2001 9
2002 12
2003 10
2004 8
2005 7
2006 8
2007 10
2008 16
2009 13
2010 17
2011 18
2012 13
2013 17
2014 19
2015 27
2016 22
2017 22
2018 35
2019 30
2020 26
2021 33
2022 19
Text availability
Article attribute
Article type
Publication date

Search Results

397 results
Results by year
Filters applied: . Clear all
Page 1
Severe cutaneous adverse reactions to drugs.
Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Duong TA, et al. Among authors: wolkenstein p. Lancet. 2017 Oct 28;390(10106):1996-2011. doi: 10.1016/S0140-6736(16)30378-6. Epub 2017 May 2. Lancet. 2017. PMID: 28476287 Review.
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC), Huson SM, Evans DG, Plotkin SR. Legius E, et al. Among authors: wolkenstein p. Genet Med. 2021 Aug;23(8):1506-1513. doi: 10.1038/s41436-021-01170-5. Epub 2021 May 19. Genet Med. 2021. PMID: 34012067 Free PMC article.
SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.
Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. Bastuji-Garin S, et al. Among authors: wolkenstein p. J Invest Dermatol. 2000 Aug;115(2):149-53. doi: 10.1046/j.1523-1747.2000.00061.x. J Invest Dermatol. 2000. PMID: 10951229 Free article.
[Phacomatosis].
Valeyrie-Allanore L, Wolkenstein P. Valeyrie-Allanore L, et al. Among authors: wolkenstein p. Rev Prat. 2008 Apr 15;58(7):717-24. Rev Prat. 2008. PMID: 18546640 Review. French.
[Disulone].
Begon E, Chosidow O, Wolkenstein P. Begon E, et al. Among authors: wolkenstein p. Ann Dermatol Venereol. 2004 Dec;131(12):1062-73. doi: 10.1016/s0151-9638(04)93842-2. Ann Dermatol Venereol. 2004. PMID: 15692440 Review. French.
MEK inhibitors in RASopathies.
Bergqvist C, Wolkenstein P. Bergqvist C, et al. Among authors: wolkenstein p. Curr Opin Oncol. 2021 Mar 1;33(2):110-119. doi: 10.1097/CCO.0000000000000711. Curr Opin Oncol. 2021. PMID: 33395032 Review.
397 results